Changes in Beneficial Ownership · 4
InspireMD Inc.
NSPRNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-11-13
- Issuer
- InspireMD, Inc.
- Issuer CIK
- 0001433607
- Trading symbol
- NSPR
Reporting owner 1
- Name
- BERMAN MICHAEL
- Reporting owner CIK
- 0001186801
- Relationship
- Director
- Address
- C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL, 33126
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-11-13 | P · Form 4 | 76,923[F1] | A | 0.65 | 429,509 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Common Stock | 244,994 | I | See Footnote[F2] |
Table key
- I
- Indirect
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series L Common Stock Warrant[F3] | 0.65 | 2026-11-13 | P · Form 4 | 57,692 | A | 0.00 | 2026-11-16 | 2027-11-16 | Common Stock | 57,692 | 57,692 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Represents shares of common stock purchased by the Reporting Person in the Issuer's underwritten public offering at a combined public offering price of $0.65 per share of common stock and accompanying Series L common stock warrants.↩ 1
- F2
- These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.↩ 1
- F3
- The Series L common stock warrants are immediately exercisable at an exercise price of $0.65 per share and expire on November 16, 2027.↩ 1
Signature 1
- Signed
- /s/ Michael Lawless, Attorney-in-Fact for Michael Berman
- Date
- 2026-11-17
Company context
InspireMD seeks to utilize its proprietary MicroNet ™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.